Cargando…

MiR‐133a‐3p attenuates resistance of non‐small cell lung cancer cells to gefitinib by targeting SPAG5

BACKGROUND: Gefitinib is an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR‐TKI), clinically used to treat patients with non‐small cell lung cancer driven by EGFR mutations. Unfortunately, EGFR‐TKI resistance has become a clinical problem for the effective treatment of NSCLC patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qing, Wang, Yueming, He, Jingdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274984/ https://www.ncbi.nlm.nih.gov/pubmed/34057242 http://dx.doi.org/10.1002/jcla.23853

Ejemplares similares

miR-874 inhibits gastric cancer cell proliferation by targeting SPAG9
por: Sun, Qin Hui, et al.
Publicado: (2020)

miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
por: Ge, Peng, et al.
Publicado: (2019)

miR-539 inhibits prostate cancer progression by directly targeting SPAG5
por: Zhang, Hongtuan, et al.
Publicado: (2016)

Relationship between miR-7 expression and treatment outcomes with gefitinib in non-small cell lung cancer
por: Mou, Kun, et al.
Publicado: (2016)

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
por: Coccia, Elena, et al.
Publicado: (2020)

Mechanism research of miR‐34a regulates Axl in non‐small‐cell lung cancer with gefitinib‐acquired resistance
por: Xiong, Ran, et al.
Publicado: (2019)

miR-135a Confers Resistance to Gefitinib in Non-Small Cell Lung Cancer Cells by Upregulation of RAC1
por: Zhang, Tingting, et al.
Publicado: (2018)

Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
por: Koutsoulidou, Andrie, et al.
Publicado: (2011)

Smad8 Is Increased in Duchenne Muscular Dystrophy and Suppresses miR-1, miR-133a, and miR-133b
por: Lopez, Michael A., et al.
Publicado: (2022)

MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance
por: Lan, Dong, et al.
Publicado: (2015)

Age-Related Exosomal and Endogenous Expression Patterns of miR-1, miR-133a, miR-133b, and miR-206 in Skeletal Muscles
por: Mytidou, Chrystalla, et al.
Publicado: (2021)

miR‐133a Replacement Attenuates Thoracic Aortic Aneurysm in Mice
por: Akerman, Adam W., et al.
Publicado: (2021)

let-7 and miR-17 promote self-renewal and drive gefitinib resistance in non-small cell lung cancer
por: Yin, Jun, et al.
Publicado: (2019)

Guanidinoacetic Acid Attenuates Adipogenesis through Regulation of miR-133a in Sheep
por: Zhao, Jia-Min, et al.
Publicado: (2023)

Cucurbitacin B enhances apoptosis in gefitinib resistant non-small cell lung cancer by modulating the miR-17-5p/STAT3 axis
por: Yu, Baodan, et al.
Publicado: (2021)

miR‐1‐3p and miR‐206 sensitizes HGF‐induced gefitinib‐resistant human lung cancer cells through inhibition of c‐Met signalling and EMT
por: Jiao, Demin, et al.
Publicado: (2018)

miR-133b Inhibits Cell Growth, Migration, and Invasion by Targeting MMP9 in Non-Small Cell Lung Cancer
por: Zhen, Yan, et al.
Publicado: (2017)

Obesity-induced inflammatory miR-133a mediates apoptosis of granulosa cells and causes abnormal folliculogenesis: Role of miR-133a in folliculogenesis
por: Chen, Ruizhi, et al.
Publicado: (2023)

Role of miR-1 and miR-133a in myocardial ischemic postconditioning
por: He, Bin, et al.
Publicado: (2011)

miR-206/133b Cluster: A Weapon against Lung Cancer?
por: Pan, Jing-Yu, et al.
Publicado: (2017)

Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion
por: Wu, Zheng-sheng, et al.
Publicado: (2012)

MiR‐873 inhibition enhances gefitinib resistance in non‐small cell lung cancer cells by targeting glioma‐associated oncogene homolog 1
por: Jin, Shidai, et al.
Publicado: (2018)

miR-19a contributes to gefitinib resistance and epithelial mesenchymal transition in non-small cell lung cancer cells by targeting c-Met
por: Cao, Xiaonian, et al.
Publicado: (2017)

miR-4487 Enhances Gefitinib-Mediated Ubiquitination and Autophagic Degradation of EGFR in Non–Small Cell Lung Cancer Cells by Targeting USP37
por: Kim, Mi Seong, et al.
Publicado: (2022)

Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson’s disease
por: Chen, Qihua, et al.
Publicado: (2021)

MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway
por: Moro, Massimo, et al.
Publicado: (2022)

miR-3113-5p, miR-223-3p, miR-133a-3p, and miR-499a-5p are sensitive biomarkers to diagnose sudden cardiac death
por: Yan, Fengping, et al.
Publicado: (2021)

LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR-9-5p and regulating SPAG9 expression
por: Yan, Pei, et al.
Publicado: (2019)

Diagnostic value of serum miR197 and miR145 in non-small cell lung cancer
por: Sui, Ankui, et al.
Publicado: (2019)

miR-133: A Suppressor of Cardiac Remodeling?
por: Li, Ning, et al.
Publicado: (2018)

miR-133a-5p Inhibits Glioma Cell Proliferation by Regulating IGFBP3
por: Yang, Xinzhi, et al.
Publicado: (2022)

The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism
por: Chen, Yao-ping, et al.
Publicado: (2016)

Gefitinib in Non Small Cell Lung Cancer
por: Costanzo, Raffaele, et al.
Publicado: (2011)

CircFOXM1 promotes proliferation and metastasis of hepatocellular carcinoma via regulating miR-1179/SPAG5 axis
por: Wang, Gaoqing, et al.
Publicado: (2021)

LncRNA H19 promotes the committed differentiation of stem cells from apical papilla via miR-141/SPAG9 pathway
por: Li, Zehan, et al.
Publicado: (2019)

Mir-1, miR-122, miR-132, and miR-133 Are Related to Subclinical Aortic Atherosclerosis Associated with Metabolic Syndrome
por: Šatrauskienė, Agnė, et al.
Publicado: (2021)

miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells
por: Sallustio, Fabio, et al.
Publicado: (2013)

miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer
por: Karatas, Omer Faruk, et al.
Publicado: (2014)

Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
por: Shen, Jie, et al.
Publicado: (2014)

Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis
por: Xue, Wei-Xiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_64lbanti7oh2c7gc03jd59vlig